Research Spotlight Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to…adminOctober 22, 2019
Research Spotlight Clinicians Answer Additional Medical Questions From LuMind IDSC Research Rally Panel Q&A The 2019 Research Rally Breakfast at the NDSC Annual Convention was attended by 400 families…adminAugust 8, 2019
Research Spotlight LIFE-DSR Study – Why Natural History Studies Are Important on the Path to New Treatments The LIFE DSR Study is the first investigation of the DS-CTN network. The study aims…adminMay 13, 2019
Research Spotlight Cerveau Technologies, Inc. Announces Partnership with LuMind IDSC to Expand LIFE DSR Study The LuMind IDSC Foundation is excited to welcome a new Research Partner to the community!…adminMay 9, 2019
Research Spotlight LuMind Research Down Syndrome Foundation Launches the Down Syndrome Clinical Trials Network BURLINGTON, Mass. , 2018 – With a combined $3M commitment from the Alana Foundation and…adminNovember 1, 2018
Research Spotlight Published results on the Roche Clinical Trials for CLEMATIS expected in the first half of 2019 Many of you have asked LuMind RDS about the publishing of the results of the Hoffman-La Roche…adminJuly 5, 2018
Research Spotlight New Trans-NIH INCLUDE Project for Down Syndrome will provide up to $261M Over 5 Years MARLBOROUGH, MA. (June 22, 2018) — On Friday, June 21, The National Institute of Health (NIH)…adminJune 22, 2018
Research Spotlight Historic ~65% increase for NIH Down syndrome research Marlborough MA, May 27, 2017 — On Thursday this week, Congress’ House Labor and Health…adminMay 26, 2018
Research Spotlight Increased Commitment to Down Syndrome Research Included in 2018 Omnibus Spending Bill New trans-NIH Down Syndrome Initiative aims for scientific discoveries to improve the health and neurodevelopment…adminMarch 23, 2018